Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LivaNova (LIVN) Capital Expenditures (2016 - 2025)

LivaNova (LIVN) has disclosed Capital Expenditures for 11 consecutive years, with $32.2 million as the latest value for Q4 2025.

  • Quarterly Capital Expenditures rose 209.75% to $32.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $81.0 million through Dec 2025, up 72.06% year-over-year, with the annual reading at $81.0 million for FY2025, 72.06% up from the prior year.
  • Capital Expenditures hit $32.2 million in Q4 2025 for LivaNova, up from $22.9 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $32.2 million in Q4 2025 to a low of $3.3 million in Q3 2021.
  • Historically, Capital Expenditures has averaged $10.8 million across 5 years, with a median of $8.5 million in 2021.
  • Biggest five-year swings in Capital Expenditures: crashed 68.82% in 2021 and later soared 209.75% in 2025.
  • Year by year, Capital Expenditures stood at $7.6 million in 2021, then rose by 20.42% to $9.1 million in 2022, then soared by 41.44% to $12.9 million in 2023, then decreased by 19.45% to $10.4 million in 2024, then skyrocketed by 209.75% to $32.2 million in 2025.
  • Business Quant data shows Capital Expenditures for LIVN at $32.2 million in Q4 2025, $22.9 million in Q3 2025, and $15.1 million in Q2 2025.